Castleman Disease

Understanding Castleman Disease: A Comprehensive Overview

What is Castleman Disease?

Castleman Disease (CD) is a rare lymphoproliferative disorder characterized by an abnormal growth of lymphoid tissue. It can manifest in various forms, primarily categorized into unicentric and multicentric types. Unicentric Castleman Disease typically affects a single lymph node, while multicentric Castleman Disease involves multiple lymph nodes and can affect other organs.

Why This Condition is Clinically Important

Castleman Disease is clinically important because its symptoms can resemble other conditions such as lymphoma or autoimmune diseases, including lymphoma and autoimmune diseases. Early diagnosis and treatment are crucial, as the disease can lead to severe complications, including organ dysfunction and increased risk of malignancies. Understanding this condition is essential for healthcare providers to ensure timely intervention and management.

Who is Commonly Affected

Castleman Disease can affect individuals of any age, but it is most commonly diagnosed in adults between the ages of 30 and 60. Both men and women are equally affected, although some studies suggest a slight male predominance. The multicentric form is more prevalent in individuals with compromised immune systems, such as those with HIV/AIDS.

Brief Overview of:

• Causes: The exact cause of Castleman Disease remains unclear, but it is believed to involve a combination of genetic, infectious, and immune system factors.
• Symptoms: Common symptoms include fever, fatigue, weight loss, night sweats, and swollen lymph nodes. In multicentric cases, patients may also experience organ dysfunction due to systemic inflammation.
• Possible Outcomes and Prognosis: The prognosis varies significantly based on the type of Castleman Disease. Unicentric cases often have a good prognosis with surgical intervention, while multicentric cases may require more complex treatment and have a variable prognosis depending on associated conditions.

Definition & Medical Overview

Clear and Simple Medical Definition

Castleman Disease is a rare disorder characterized by the overgrowth of lymphoid tissue, leading to enlarged lymph nodes and potential systemic effects. It is classified into unicentric and multicentric forms, each with distinct clinical features and management strategies.

How the Condition Affects the Body

In Castleman Disease, the lymphatic system, which plays a crucial role in immune function, becomes dysfunctional. This can lead to excessive production of certain proteins and cytokines, resulting in inflammation and various systemic symptoms.

Organs or Body Systems Involved

• Lymphatic System: The primary site of involvement, with lymph nodes becoming enlarged.
• Immune System: Dysregulation can lead to increased susceptibility to infections.
• Other Organs: In multicentric cases, the liver, spleen, and bone marrow may also be affected, leading to complications such as organ failure.

Acute vs Chronic Nature

Castleman Disease can present acutely, particularly in unicentric cases where symptoms may develop rapidly following lymph node enlargement. In contrast, multicentric Castleman Disease often has a chronic course, with symptoms persisting over time and requiring ongoing management.

How It Differs from Similar Conditions

Castleman Disease is distinct from lymphoma, although it can mimic its symptoms. Unlike lymphoma, which is a malignancy of lymphoid tissue, Castleman Disease is a non-cancerous hyperplastic condition. It also differs from autoimmune diseases, which primarily involve immune system dysregulation without the characteristic lymph node enlargement seen in Castleman Disease.

Epidemiology & Prevalence

Global Prevalence and Burden

Castleman Disease is considered rare, with an estimated incidence of 1-5 cases per million people annually. Unicentric Castleman Disease is more common and accounts for the majority of cases. Multicentric Castleman Disease is less common but typically more severe and often associated with conditions such as HIV infection or human herpesvirus-8 (HHV-8).

India-Specific Relevance or Trends

In India, the awareness and diagnosis of Castleman Disease are gradually improving, but it remains underrecognized. The prevalence may be influenced by the higher rates of infectious diseases, such as HIV, which are associated with multicentric Castleman Disease.

Age-Wise, Gender-Wise, and Risk Group Distribution

• Age: Most commonly diagnosed in adults aged 30-60.
• Gender: A slight male predominance is observed, particularly in multicentric cases.
• Risk Groups: Individuals with compromised immune systems, such as those with HIV/AIDS, are at higher risk for multicentric Castleman Disease.

Causes & Risk Factors

Primary and Secondary Causes

The exact cause of Castleman Disease is not fully understood. The exact cause of Castleman Disease is not fully understood. It is believed to involve abnormal immune system activity and, in some cases, viral infections such as human herpesvirus-8 (HHV-8).

Role of:

• Genetics: Castleman Disease is generally not considered a hereditary condition. Most cases occur sporadically, meaning they develop without a clear inherited genetic cause.
• Lifestyle: Factors such as smoking and diet may influence immune function but are not directly linked to Castleman Disease.
• Environmental Exposure: Infection with human herpesvirus-8 (HHV-8) is strongly associated with some cases of multicentric Castleman Disease, particularly in individuals with HIV. In other cases, the disease occurs without a known viral cause and is referred to as idiopathic multicentric Castleman Disease (iMCD).
• Infections: Certain infections, particularly human herpesvirus-8 (HHV-8), are known to play a role in some cases of multicentric Castleman Disease.
• Autoimmune or Metabolic Factors: Dysregulation of the immune system, often seen in autoimmune diseases, may contribute to the development of Castleman Disease.

Modifiable vs Non-Modifiable Risk Factors

• Modifiable: Lifestyle choices, such as smoking cessation and maintaining a healthy immune system, may reduce risk.
• Non-Modifiable: Age, gender, and genetic predisposition are factors that cannot be changed.

Pathophysiology (Explained Simply)

What Happens Inside the Body Step by Step

• Immune System Activation: In Castleman Disease, the immune system becomes overly activated, often due to infections or other triggers.
• Lymph Node Enlargement: This activation leads to the proliferation of lymphoid tissue, causing lymph nodes to enlarge.
• Cytokine Release: The overactive immune response leads to the release of inflammatory proteins called cytokines. One of the most important is interleukin-6 (IL-6), which plays a major role in causing inflammation and many of the symptoms seen in multicentric Castleman Disease.
• Systemic Effects: The excessive cytokine production can lead to systemic symptoms such as fever, fatigue, and weight loss, as well as complications affecting other organs.
• Progression: In multicentric cases, the disease can progress, leading to more severe symptoms and potential organ dysfunction.

How the Disease Develops and Progresses Biologically

Castleman Disease begins with an abnormal immune response, often triggered by infections or genetic factors. This response leads to the uncontrolled growth of lymphoid tissue, resulting in the clinical manifestations of the disease. Over time, if left untreated, the condition can lead to significant health complications, including organ failure and increased risk of malignancies.

Simplified Explanation Suitable for Non-Medical Readers

In simple terms, Castleman Disease is like a malfunction in the body's defense system. Instead of working properly to fight infections, the immune system goes into overdrive, causing certain parts of the body, like lymph nodes, to swell. This can lead to various symptoms and complications, making it essential to understand and manage the condition effectively.

Symptoms, Clinical Presentation & Diagnosis

Signs & Symptoms

Castleman Disease (CD) presents with a variety of symptoms that can vary significantly among individuals. Understanding these symptoms is crucial for early detection and management.

Common Early Symptoms

Early symptoms of Castleman Disease may be subtle and can often be mistaken for other conditions. Common early signs include:

• Fatigue: Persistent tiredness that does not improve with rest.
• Fever: Unexplained fevers that may come and go.
• Night Sweats: Excessive sweating during the night.
• Weight Loss: Unintentional weight loss over a short period.
• Swollen Lymph Nodes: Painless swelling in the neck, armpits, or groin.

Progressive and Advanced Symptoms

As the disease progresses, symptoms may become more pronounced and can include:

• Severe Fatigue: Increased tiredness that affects daily activities.
• Persistent Fever: Continuous or recurrent fevers that may be high-grade.
• Anemia: Symptoms such as weakness, pallor, and shortness of breath due to low red blood cell counts.
• Abdominal Pain: Discomfort or pain in the abdomen, often due to enlarged lymph nodes.
• Organ Dysfunction: Symptoms related to affected organs, such as liver or kidney issues.

Differences Between Mild, Moderate, and Severe Presentations

• Mild Presentation: May include fatigue, mild fever, and occasional night sweats. Patients often remain functional and may not seek immediate medical attention.
• Moderate Presentation: Symptoms become more pronounced, with persistent fever, noticeable weight loss, and swollen lymph nodes. Patients may experience limitations in daily activities.
• Severe Presentation: Characterized by significant organ involvement, severe anemia, and debilitating symptoms. Patients often require urgent medical intervention.

Variations in Symptoms Among Different Age Groups

• Children: Symptoms in children may include growth delays, recurrent infections, and abdominal pain. They may also present with more pronounced lymphadenopathy.
• Adults: Adults typically experience systemic symptoms like fever, night sweats, and weight loss, along with potential organ involvement.
• Elderly Patients: Older adults may present with atypical symptoms, such as confusion or cognitive changes, alongside the common systemic symptoms. They may also have a higher risk of complications.

Atypical or Less Common Symptoms

Some patients may experience atypical symptoms, which can include:

• Skin Rashes: Unexplained rashes or skin lesions.
• Neurological Symptoms: Headaches, dizziness, or changes in vision.
• Gastrointestinal Symptoms: Nausea, vomiting, or changes in bowel habits.

Red-Flag Symptoms & When to Seek Medical Attention

Certain symptoms warrant immediate medical evaluation due to the potential for serious complications.

Symptoms That Require Urgent or Emergency Care

• Severe Abdominal Pain: Sudden, intense pain that may indicate organ involvement.
• High Fever: Persistent fever above 101°F (38.3°C) that does not respond to over-the-counter medications.
• Difficulty Breathing: Shortness of breath or wheezing that worsens.
• Severe Weakness: Sudden onset of weakness or inability to perform daily tasks.

Situations Where Immediate Hospital Evaluation is Needed

• Rapid Weight Loss: Losing more than 5% of body weight in a month without trying.
• Confusion or Altered Mental Status: Sudden changes in cognition or awareness.
• Severe Swelling: Rapid swelling of lymph nodes or extremities.

Risks Associated with Ignoring or Delaying Medical Consultation

Delaying medical attention can lead to:

• Worsening Symptoms: Progression of the disease and increased severity of symptoms.
• Complications: Potential organ damage or failure.
• Poor Prognosis: Delayed diagnosis can affect treatment options and outcomes.

Clinical Evaluation & Initial Assessment

A thorough clinical evaluation is essential for diagnosing Castleman Disease.

How Doctors Assess Symptoms

• Medical History: A detailed history of symptoms, duration, and any previous health issues.
• Family History: Inquiry about any family history of lymphoproliferative disorders or related conditions.
• Lifestyle and Risk Assessment: Discussion of lifestyle factors, including exposure to infections or environmental toxins.

Physical Examination Findings Relevant to the Condition

During the physical examination, doctors may look for:

• Lymphadenopathy: Enlarged lymph nodes in various regions.
• Splenomegaly: Enlargement of the spleen, which may be palpable.
• Signs of Anemia: Pallor or other signs indicating low hemoglobin levels.

Diagnostic Tests & Investigations

A variety of diagnostic tests are utilized to confirm Castleman Disease.

Blood Tests

• Complete Blood Count (CBC): To check for anemia, leukopenia, or thrombocytopenia.
• Inflammatory Markers: Tests like ESR or CRP to assess inflammation levels.

Imaging Studies

• X-ray: Occasionally used to evaluate chest lymph nodes or other abnormalities.
• Ultrasound: Useful for assessing lymph node size and abdominal organs.
• CT Scan: Provides detailed images of lymph nodes and organ involvement.
• MRI: May be used for soft tissue evaluation.
• PET Scan: Helps in assessing metabolic activity of lymph nodes.

Functional Tests or Specialised Diagnostics

• Liver Function Tests: To evaluate liver involvement.
• Kidney Function Tests: To assess renal health.

Biopsy or Invasive Tests

• Lymph Node Biopsy: Essential for definitive diagnosis, allowing histological examination.
• Bone Marrow Biopsy: May be performed to assess bone marrow involvement.

Purpose and Interpretation of Key Investigations

These investigations help in:

• Confirming Diagnosis: Distinguishing Castleman Disease from other conditions.
• Assessing Severity: Understanding the extent of disease involvement.
• Guiding Treatment: Informing the management plan based on findings.

Differential Diagnosis

Castleman Disease can mimic several other conditions, making accurate diagnosis critical.

Conditions with Similar Symptoms

• Lymphoma: Often presents with similar lymphadenopathy and systemic symptoms.
• Infections: Such as tuberculosis or HIV, which can cause fever and lymph node enlargement.
• Autoimmune Disorders: Conditions like lupus or rheumatoid arthritis may present with systemic symptoms.

How Doctors Distinguish Castleman Disease from Other Disorders

• Histological Examination: Biopsy results are crucial for differentiating CD from lymphoma.
• Clinical Presentation: The specific combination of symptoms and their progression can aid in diagnosis.

Importance of Accurate Diagnosis

An accurate diagnosis is vital for:

• Appropriate Treatment: Ensuring the right management strategy is employed.
• Prognosis: Understanding the likely course of the disease and potential outcomes.

Staging, Grading, or Classification

Understanding the stage or grade of Castleman Disease is important for treatment planning.

Disease Stages, Grades, or Severity Classifications

• Localized Castleman Disease: Typically involves a single lymph node region.
• Multicentric Castleman Disease: Involves multiple lymph node regions and may affect organ function.

What Each Stage or Grade Means Clinically

• Localized: Often has a better prognosis and may be treated with surgical excision.
• Multicentric: Associated with more severe symptoms and requires systemic treatment.

How Staging Influences Treatment Decisions and Outcomes

• Treatment Options: Staging helps determine whether surgery, chemotherapy, or targeted therapies are appropriate.
• Monitoring: Staging informs follow-up strategies and monitoring for disease progression.

Treatment, Management, Recovery & Prevention

Treatment Options

Medical Management and Medications

Castleman Disease (CD) treatment varies based on the type of disease. Unicentric Castleman Disease usually involves a single lymph node and is often treated with surgery, while multicentric Castleman Disease affects multiple lymph nodes and requires systemic medical therapy. The primary goal is to manage symptoms and control the disease's progression.

• Corticosteroids: These medications may be used to reduce inflammation and control symptoms, particularly during disease flare-ups or as part of combination treatment.
• Immunotherapy: Agents like rituximab target specific immune cells, providing relief for patients with multicentric Castleman disease.
• Anti-IL-6 therapy: Medications such as siltuximab target interleukin-6 (IL-6), a key inflammatory protein involved in multicentric Castleman Disease. These drugs are considered an important first-line treatment for many patients with idiopathic multicentric Castleman Disease.
• Chemotherapy: In severe or treatment-resistant multicentric Castleman Disease, chemotherapy drugs may be used to control abnormal lymph node growth and immune activity.
• Targeted therapies: Newer treatments, such as tocilizumab, have shown promise in managing multicentric Castleman disease by inhibiting interleukin-6, a key player in inflammation.

Non-Surgical Therapies and Supportive Treatments

Supportive care is crucial in managing symptoms and improving quality of life.

• Pain management: Analgesics and other pain relief methods can help manage discomfort.
• Nutritional support: A dietitian can assist in creating a balanced diet to combat weight loss and malnutrition.
• Physical therapy: Tailored exercise programs can help maintain mobility and strength.

Surgical or Interventional Procedures

For unicentric Castleman disease, surgical intervention may be necessary.

• Surgical excision: Removing the affected lymph node can lead to complete resolution of symptoms in unicentric cases.
• Interventional radiology: Techniques such as embolization may be used to manage vascular complications.

Advanced or Minimally Invasive Treatment Options

Minimally invasive techniques are becoming more common in managing Castleman disease.

• Endoscopic procedures: These can be used for biopsy or to relieve symptoms caused by lymph node enlargement.

Individualized Treatment Planning

Treatment plans should be tailored to each patient, considering:

• Disease severity: Multicentric cases often require more aggressive treatment.
• Age and comorbidities: Older patients or those with other health issues may need modified approaches to minimize risks.

Lifestyle & Supportive Care

Dietary Recommendations

Nutrition plays a vital role in recovery and overall health.

• Balanced diet: Emphasize fruits, vegetables, whole grains, and lean proteins.
• Hydration: Adequate fluid intake is essential, especially if experiencing fever or sweating.

Physical Activity and Rehabilitation

Maintaining physical activity is important for overall well-being.

• Gentle exercises: Activities like walking or yoga can help improve strength and flexibility.
• Rehabilitation programs: Tailored programs can assist in regaining strength post-treatment.

Lifestyle Modifications

Making certain lifestyle changes can enhance quality of life.

• Stress management: Techniques such as meditation or mindfulness can help manage stress levels.
• Sleep hygiene: Prioritizing good sleep can aid recovery and overall health.

Mental Health and Emotional Support

Emotional well-being is crucial for patients and their families.

• Counseling: Professional support can help patients cope with the emotional impact of the disease.
• Support groups: Connecting with others facing similar challenges can provide comfort and understanding.

Patient Education and Self-Management Strategies

Empowering patients with knowledge is key.

• Understanding the disease: Educating patients about Castleman disease helps them make informed decisions.
• Self-monitoring: Keeping track of symptoms and treatment responses can aid in timely medical consultations.

Complications & Risks

Short-Term Complications

Immediate complications can arise from the disease or its treatment.

• Infections: Immunosuppression from treatment can increase infection risk.
• Anemia: Blood loss or bone marrow involvement may lead to anemia.

Long-Term Complications

Chronic issues may develop over time.

• Organ dysfunction: Prolonged disease can affect organ function, particularly the liver and kidneys.
• Secondary malignancies: Patients with multicentric Castleman disease may have an increased risk of developing other cancers.

Risks Associated with Delayed Treatment or Poor Disease Control

Timely intervention is crucial.

• Disease progression: Delayed treatment can lead to worsening symptoms and complications.
• Quality of life: Poor disease control can significantly impact daily functioning and emotional well-being.

Impact on Overall Health and Quality of Life

Castleman disease can affect various aspects of life.

• Physical health: Chronic symptoms can lead to fatigue and decreased physical activity.
• Emotional health: The stress of living with a chronic illness can lead to anxiety and depression.

Recovery & Prognosis

Expected Recovery Timeline

Recovery varies based on treatment and individual factors.

• Acute recovery: Patients may start feeling better within weeks of treatment initiation.
• Long-term recovery: Full recovery can take months, especially for those with multicentric disease.

Factors Affecting Recovery and Outcomes

Several factors influence recovery.

• Type of Castleman disease: Unicentric cases generally have a better prognosis than multicentric.
• Patient's overall health: Comorbidities can complicate recovery.

Long-Term Prognosis

The outlook for patients varies.

• Unicentric Castleman disease: Often curable with surgery.
• Multicentric Castleman disease: More complex, with variable outcomes depending on treatment response.

Recurrence Risk

Understanding the risk of recurrence is important.

• Unicentric cases: Low recurrence risk post-surgery.
• Multicentric cases: Higher risk of relapse, necessitating ongoing monitoring.

Impact on Daily Functioning

Castleman disease can affect daily life.

• Fatigue and weakness: These symptoms can limit daily activities and social interactions.
• Emotional challenges: Coping with a chronic illness can impact relationships and work life.

Prevention & Risk Reduction

Primary Prevention Strategies

While there are no known prevention methods for Castleman disease, general health practices can be beneficial.

• Healthy lifestyle: A balanced diet and regular exercise can support immune function.
• Avoiding infections: Good hygiene practices can reduce the risk of infections, especially for immunocompromised patients.

Secondary Prevention and Early Detection

Early detection is crucial for better outcomes.

• Regular check-ups: Monitoring for symptoms can lead to timely diagnosis and treatment.
• Awareness of symptoms: Patients should be educated about signs that warrant medical attention.

Lifestyle-Based Risk Reduction

Adopting a healthy lifestyle can mitigate risks.

• Avoiding tobacco and excessive alcohol: These substances can weaken the immune system.
• Stress management: Reducing stress can improve overall health and resilience.

Screening or Monitoring Recommendations

Regular follow-ups are essential for managing Castleman disease.

• Routine blood tests: Monitoring blood counts and inflammatory markers can help assess disease status.
• Imaging studies: Periodic scans may be necessary to evaluate lymph node status.

Living With Castleman Disease

Day-to-Day Life Considerations

Living with Castleman disease requires adjustments.

• Energy management: Patients may need to pace themselves to avoid fatigue.
• Support systems: Relying on family and friends can provide emotional and practical support.

Work, Travel, and Social Life

Maintaining a social life is important for emotional health.

• Work accommodations: Flexible work arrangements may be necessary during treatment.
• Travel considerations: Patients should consult healthcare providers before traveling, especially if immunocompromised.

Long-Term Monitoring and Follow-Up Care

Ongoing care is vital for managing Castleman disease.

• Regular appointments: Follow-ups with healthcare providers can help monitor disease status and adjust treatment as needed.
• Patient education: Continuous education about the disease and its management is essential.

Coping Strategies for Patients and Caregivers

Coping with Castleman disease can be challenging.

• Open communication: Discussing feelings and concerns with loved ones can alleviate stress.
• Seeking professional help: Therapy or counseling can provide additional support.

Conclusion

Castleman disease presents unique challenges, but with appropriate treatment and support, many patients can manage their symptoms effectively. Understanding treatment options, lifestyle modifications, and the importance of ongoing care can empower patients and their families. If you or a loved one is experiencing symptoms of Castleman disease, timely medical consultation is crucial. Remember, you are not alone in this journey; support is available, and proactive management can lead to improved outcomes and quality of life.

FAQs

1. What is Castleman Disease?

Castleman Disease is a rare lymphoproliferative disorder characterized by an overgrowth of lymphoid tissue. It can present in two main forms: unicentric, affecting a single lymph node, and multicentric, involving multiple nodes and systemic symptoms. The exact cause remains unclear, but it is associated with immune system dysregulation.

2. Is Castleman Disease serious or life-threatening?

Yes, Castleman Disease can be serious and, in some cases, life-threatening—particularly the multicentric form. Multicentric Castleman Disease can lead to severe complications such as organ dysfunction, increased susceptibility to infections, and, in advanced cases, organ failure. Early diagnosis and prompt treatment are essential to manage the condition effectively and reduce the risk of serious complications.

3. Is Castleman Disease curable or only manageable?

Castleman Disease is not universally curable, but it can be managed effectively. Treatment options may lead to remission, particularly in unicentric cases. Multicentric cases often require ongoing management to control symptoms and prevent complications.

4. What causes Castleman Disease?

The exact cause of Castleman Disease is not fully understood. It is believed to involve an abnormal immune response, possibly triggered by infections, autoimmune diseases, or certain cancers. Human herpesvirus 8 (HHV-8) is linked to some cases, particularly multicentric Castleman Disease.

5. What are the early warning signs?

Early warning signs of Castleman Disease may include unexplained fever, night sweats, weight loss, fatigue, and swollen lymph nodes. If you experience these symptoms, it’s important to consult a healthcare professional for evaluation.

6. When should I see a doctor?

You should see a doctor if you experience persistent symptoms such as swollen lymph nodes, unexplained fever, or significant weight loss. Early consultation can help in diagnosing and managing potential underlying conditions like Castleman Disease.

7. Is this condition genetic or hereditary?

Castleman Disease is not typically considered hereditary. However, certain genetic factors may influence susceptibility. Most cases arise sporadically without a family history.

8. Can Castleman Disease be prevented?

Currently, there are no known preventive measures for Castleman Disease. Awareness of symptoms and early medical consultation can help in timely diagnosis and management.

9. What foods should be avoided with this condition?

While there are no specific dietary restrictions for Castleman Disease, a balanced diet that supports overall health is recommended. Patients should avoid processed foods and excessive sugar, which can impact immune function.

10. Can lifestyle changes improve this condition?

Lifestyle changes, such as maintaining a healthy diet, regular exercise, and stress management, can support overall well-being and may help improve quality of life for those with Castleman Disease. Always consult your doctor before making significant changes.

11. How is Castleman Disease treated in India?

Treatment for Castleman Disease in India may include surgery (for unicentric disease), immunotherapy such as rituximab, targeted therapies that block interleukin-6, corticosteroids, or chemotherapy depending on the type and severity of the disease. Multidisciplinary care involving hematologists and oncologists is often necessary for optimal management.

12. When is surgery required?

Surgery may be required for unicentric Castleman Disease to remove the affected lymph node. In cases where the disease is localized and causing symptoms, surgical intervention can lead to significant improvement.

13. How long does recovery take?

Recovery time varies based on the type of Castleman Disease and the treatment approach. After surgery, patients may take several weeks to months to fully recover, while those undergoing medical treatment may require ongoing management.

14. Can the condition come back after treatment?

Yes, Castleman Disease can recur, particularly in multicentric cases. Regular follow-up with healthcare providers is essential to monitor for any signs of recurrence and to manage the condition effectively.

15. When should I seek emergency medical care?

Seek emergency medical care if you experience severe symptoms such as difficulty breathing, chest pain, sudden swelling, or high fever. These may indicate complications that require immediate attention.